A Biomimetic, Silaffin R5-Based Antigen Delivery Platform.

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Nature provides biocompatible, evolutionary optimized materials for biomimetic applications.
• Silaffin proteins, found in diatoms, are key to silica biomineralization and can form silica in vitro.
• Peptides R5 and RRIL are derived from silaffin proteins.

Purpose of the Study:

• To explore the use of biomimetic silica particles as a vaccine delivery and adjuvant platform.
• To link peptide antigens to R5 and RRIL motifs for creating antigen-loaded silica particles.
• To evaluate the immune-stimulating properties of these novel vaccine particles.

Main Methods:

• Synthesized biomimetic silica particles by linking R5 and RRIL peptides to various peptide antigens.
• Investigated the intracellular uptake of the synthesized silica particles.
• Assessed the particles' ability to induce NETosis in human neutrophils.
• Measured IL-6 and TNF-α secretion in murine bone marrow-derived dendritic cells.

Main Results:

• Successfully created antigen-loaded biomimetic silica particles.
• Demonstrated efficient intracellular uptake of the silica particles.
• Observed induction of NETosis in human neutrophils.
• Confirmed secretion of IL-6 and TNF-α in murine dendritic cells.

Conclusions:

• Biomimetic silica particles serve as a promising platform for vaccine delivery and adjuvant action.
• The developed particles combine biomaterial advantages with effective cellular uptake.
• These findings support the potential of silica-based nanoparticles in vaccine development.